Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis.
about
Biological response at the cellular level within the periodontal ligament on application of orthodontic force - An updatePeriodontal and inflammatory bowel diseases: Is there evidence of complex pathogenic interactions?The Cytolethal Distending Toxin Contributes to Microbial Virulence and Disease Pathogenesis by Acting As a Tri-Perditious ToxinPotassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal diseaseRANK/RANKL/OPG Signalization Implication in Periodontitis: New Evidence from a RANK Transgenic Mouse Model.Saliva as a diagnostic fluid.Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease.Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients.B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal diseaseEnhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cellsReceptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery.MAPK usage in periodontal disease progression.RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease.Are cementoblasts a subpopulation of osteoblasts or a unique phenotype?Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin.Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis.Novel host response therapeutic approaches to treat periodontal diseases.Gingival crevicularfluid osteoprotegerin levels in Indian population.Serum, saliva, and GCF concentration of RANKL and osteoprotegerin in smokers versus nonsmokers with chronic periodontitisRANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.Mechanisms of tooth eruption and orthodontic tooth movement.N-3 polyunsaturated fatty acid effect in periodontal disease: state of art and possible mechanisms involved.Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and healthPolymorphisms of Il-10 (-1082) and RANKL (-438) Genes and the Failure of Dental Implants.Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis.Role of osteoclasts and interleukin-17 in the pathogenesis of rheumatoid arthritis: crucial 'human osteoclastology'.The RANKL-OPG system in clinical periodontology.The receptor activator of NF-κB ligand-osteoprotegerin system in pulpal and periapical disease.Expression of Toll-like receptors 2 and 4 and the OPG-RANKL-RANK system in inflammatory external root resorption and external cervical resorption.A preliminary investigation of short-term cytokine expression in gingival crevicular fluid secondary to high-level orthodontic forces and the associated root resorption: case series analytical studyThe osteoimmunology of alveolar bone loss.Biomarkers and Bacteria Around Implants and Natural Teeth in the Same Individuals.Tumor necrosis factor-α enhances RANKL expression in gingival epithelial cells via protein kinase A signaling.The presence of RANKL-OPG complex in human osteosarcoma U2OS.Transient receptor potential vanilloid-1 regulates osteoprotegerin/RANKL homeostasis in human periodontal ligament cells.Receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in gingival crevicular fluid.The presence of TRAIL-OPG complex in human osteosarcoma and human salivary gland adenocarcinoma.A dominant function of p38 mitogen-activated protein kinase signaling in receptor activator of nuclear factor-kappaB ligand expression and osteoclastogenesis induction by Aggregatibacter actinomycetemcomitans and Escherichia coli lipopolysaccharide.Clinical, radiographic, microbiological, and immunological outcomes of flapped vs. flapless dental implants: a prospective randomized controlled clinical trial.Tumor necrosis factor-alpha-converting enzyme (TACE) levels in periodontal diseases.
P2860
Q26853236-9ED9166F-E07E-4255-BFEF-5BCC900B2DCAQ28069324-76F994D3-0565-4A06-9344-84E3C8F491AEQ28079416-65A0AA9E-6251-45B1-BECB-8AECA2C6E48BQ28252713-D9C86B1D-E05F-4FA1-A18C-AAECE07308F4Q33720589-5186DE5D-F7EE-4177-BFCB-0AA5CE4664C8Q33752749-ADB22875-2D65-4438-8604-7810D7FF763BQ34886943-AF1B44FE-71CD-4839-A31C-085477CB9126Q35178030-4758F18F-04C1-46A7-AA2B-90CB95F15D3AQ35222008-5308D495-6BD6-4E3F-A7F7-4E685D575031Q35588448-A598284D-5FBB-40B3-942E-A6A4771D94FDQ35631696-EBE08F6D-9744-4587-B255-E6C0F1170341Q35725536-3D2B6367-95D1-44DA-A44E-42FC7C078195Q35766784-D9ADA287-6613-42EC-B9C3-9BC975DF7883Q36102523-15673B31-5AD8-4AA2-B70D-816C49A5CB08Q36212648-F0653CAC-76C5-4B42-A56C-D109A4DB0329Q36518539-FFBEB9D2-0168-4E1E-B5F9-DE2D90371636Q36703987-88F20378-8E8F-474F-918A-B53989914143Q36728407-0BA0A361-F9A1-4A65-BD09-324599FDFCC9Q36890699-97AED734-9D6E-404F-BA6C-E182809629DCQ36973041-06BCA7ED-1B1B-4EE5-8CD3-FFC60B77B3E6Q37146973-A42D171B-67BF-4567-8F7F-E6A12A2F8F85Q37189117-D77928AC-8EFF-4478-B49A-A21045C7DBF9Q37303570-29C642A4-B668-43A4-8902-2FD0A6A94D3DQ37699975-69C929E1-01B6-486E-86D7-8BB50A092AD3Q37842635-08CBBFC2-7B43-4223-9E97-71822CFA7DBAQ37940890-799FEA0B-B839-4559-BE3D-17F6F0531D41Q37957292-9E5B4E6D-F586-4AE1-83BD-B00C76A7B946Q38035357-452336D3-424B-4FE6-ADA0-25268B4FAFBDQ38397625-C7CB8381-79E4-4717-845C-F5A879276686Q38648850-4357DF95-7CA7-4F28-B8C8-735076DA4AA1Q38763612-70FD0AD0-E937-4139-B32D-D39B628D07DAQ38821045-CEC5CC70-FFFE-4AA4-B347-4DA42673E439Q39084673-671E689F-1E42-425C-8651-2FB149ABB3AAQ39125121-842ACAD3-994F-4393-8FE4-21C509867033Q39348041-F824F4A9-ACB0-4C66-B149-C99298D5B63EQ39439901-A5CC3CA7-29D0-4BBA-8788-116B95644D4DQ39604830-378AFCF9-5BC7-48BA-9AF8-A6D91D7F872FQ40008685-122B8F3B-2D5F-4E11-BFF9-9925959C1243Q40042324-04867EE3-EBB7-4EC8-994E-9F27EE142981Q40120823-75574BEB-746E-4E13-804F-4B11D31E37F0
P2860
Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Differential expression of RAN ...... f patients with periodontitis.
@en
Differential expression of RAN ...... f patients with periodontitis.
@nl
type
label
Differential expression of RAN ...... f patients with periodontitis.
@en
Differential expression of RAN ...... f patients with periodontitis.
@nl
prefLabel
Differential expression of RAN ...... f patients with periodontitis.
@en
Differential expression of RAN ...... f patients with periodontitis.
@nl
P2093
P2860
P1476
Differential expression of RAN ...... f patients with periodontitis.
@en
P2093
P2860
P304
P356
10.1177/154405910408300216
P407
P577
2004-02-01T00:00:00Z